We exist to ensure all patients have access to early cardiac and pulmonary disease detection and high quality care that improves and extends their lives.
We believe the ability to listen is the ability to care. Which is why we’re dedicated to providing healthcare professionals with industry leading digital tools to hear and understand their patients’ hearts and lungs — allowing them to detect with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible.
Hear clearly. Care confidently.
We believe the ability to listen is the ability to care. Which is why we’re dedicated to providing healthcare professionals with industry leading digital tools to hear and understand their patients’ hearts and lungs — allowing them to detect with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible.
Hear clearly. Care confidently.
Location: United States, California, Oakland
Employees: 51-200
Phone: +1 844-356-3384
Total raised: $162.7M
Founded date: 2013
Investors 2
| Date | Name | Website |
| - | Startup Cr... | startupcre... |
| 14.01.2021 | Plug and P... | plugandpla... |
Funding Rounds 6
| Date | Series | Amount | Investors |
| 06.06.2024 | Series D | $41M | - |
| 20.09.2022 | Grant | $2.7M | - |
| 22.03.2022 | Series C | $30M | - |
| 09.11.2020 | Series C | $65M | - |
| 07.01.2020 | - | $4M | - |
| 25.09.2019 | Series B | $20M | - |
Mentions in press and media 18
| Date | Title | Description |
| 06.06.2024 | Eko Health Secures $41 Million to Revolutionize Heart and Lung Detection | Eko Health, a trailblazer in the realm of AI-powered early detection of heart and lung diseases, has successfully closed a Series D financing round, raising an impressive $41 million. This significant funding round, spearheaded by ARTIS Ven... |
| 06.06.2024 | Eko Health raises $41M to build out its AI-based smart stethoscopes | The company is looking to expand globally into the EU, South Korea, Japan, and Singapore Cardiovascular and pulmonary diseases are among the leading causes of death worldwide, with millions of patients unaware of their risk factors, often d... |
| 05.06.2024 | Eko Health Raises $41M in Series D Funding | Eko Health, a SanFrancisco, CA-based company which specializes in applying artificial intelligence for early detection of heart and lung diseases, raised $41M in Series D funding. Backers included ARTIS Ventures, Highland Capital Partners, ... |
| 05.06.2024 | Eko Health Raises $41M to Scale AI-driven Heart, Lung Detection | What You Should Know: – Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced today a successful Series D financing round of $41 million. – This funding, led by ARTIS Ventures, Highland Capital Partners, N... |
| 05.06.2024 | Exclusive: Eko Health nets $41M for remote heart and lung tech | figcaption>span]:font-sans"> Eko Health, a developer of technology to detect heart and lung disease remotely, raised a $41 million Series D, CEO Connor Landgraf tells Axios exclusively. Why it matters: Eko aims to enable a wide r... |
| 02.04.2024 | 15-Second Heart Failure Test: Eko’s AI Stethoscope Gets FDA Nod | What You Should Know: – Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI. – Built in collaboration with Mayo Clinic, the AI allows U.S. healthcare providers to d... |
| 02.04.2024 | Eko gets FDA clearance for AI to detect heart failure | The company's low ejection fraction detection AI was developed along with the Mayo Clinic Heart failure with reduced ejection fraction (HFrEF) happens when the heart's left ventricular ejection fraction (LVEF) is 40% or less, a sign of a we... |
| 20.09.2022 | Eko Lands $2.7M NIH Grant to Train Pulmonary Hypertension AI | What You Should Know: Pulmonary hypertension is a severe condition that occurs when the pressure in the vessels that carry blood from the heart to the lungs is higher than normal, causing undo stress on the heart. PH affects up to 1% of the... |
| 22.03.2022 | Eko expands algorithmic heart problem detection and lands $30M Series C extension | The stethoscope has come a long way from its humble beginnings in the 19th century. The regular acoustic type is still used every day, but it’s been joined by a panoply of digital options that can amplify or convert heart sounds into electr... |
| 09.11.2020 | Digital stethoscope maker Eko nets $65M to develop home telehealth offerings | As the use of telehealth continues to surge—promising a way to deliver distanced care in spite of the coronavirus, and potentially a new normal in a post-pandemic world—the makers of a digital, connected stethoscope have raised new funds to... |
Show more